title: Recurrent IgA Nephropathy After Kidney Transplantation.
abstract: Large numbers of patients with end-stage kidney disease caused by IgA nephropathy are transplanted every year, and each of these patients faces the risk of recurrence in their kidney graft. We review the epidemiology, diagnosis, and outcomes of recurrent IgA nephropathy. Mechanistic insights, therapeutic options, and knowledge gaps are reviewed, and we discuss future options to better understand and manage this disorder.
authors.affiliation: 1 Department of Renal Medicine and Transplantation, Royal Prince Alfred Hospital, Sydney, Australia. 2 Kidney Node, Charles Perkins Centre, Sydney Medical School, University of Sydney, Sydney, Australia. 3 Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Adelaide, Australia.
authors.forename: Melanie L
authors.initials: ML
authors.lastname: Wyld
authors.forename: Steven J
authors.initials: SJ
authors.lastname: Chadban
mesh_terms: D001706:Biopsy; D005922:Glomerulonephritis, IGA / Q000150:complications* / Q000175:diagnosis / Q000276:immunology / Q000401:mortality; D006801:Humans; D007668:Kidney / Q000276:immunology / Q000473:pathology / Q000601:surgery*; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000209:etiology / Q000401:mortality / Q000601:surgery*; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000401:mortality; D011237:Predictive Value of Tests; D012008:Recurrence; D019233:Retreatment; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome